ResMed Inc. (RMD.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
As of 11:00AM AEST. Market open.
| Previous close | 28.32 |
| Open | 28.58 |
| Bid | 28.55 x 51100 |
| Ask | 28.56 x 25600 |
| Day's range | 28.44 - 28.68 |
| 52-week range | 21.14 - 36.37 |
| Volume | |
| Avg. volume | 2,112,785 |
| Market cap | 42.009B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 30.38 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.29 (1.02%) |
| Ex-dividend date | 07 Feb 2024 |
| 1y target est | N/A |
- Zacks
Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
ResMed (RMD) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
Beyond analysts' top -and-bottom-line estimates for ResMed (RMD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
- Investor's Business Daily
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
ResMed stock jumped Thursday after an analyst suggested the growing popularity of weight-loss drugs could drive use of its medical devices.
© 2024 Yahoo. All rights reserved.